Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04356989
What this trial is testing

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 493
Not applicableStudy completedNCT05321810
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 193,565
Not applicableStudy completedNCT02631057
What this trial is testing

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,313
Not applicableStudy completedNCT02663076
What this trial is testing

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Chronic Kidney Disease (CKD)
GWT-TUD GmbH 1,700
Not applicableNot Yet RecruitingNCT04956978
What this trial is testing

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Who this might be right for
Atrial Fibrillation
Duke University 40
Not applicableStudy completedNCT05051904
What this trial is testing

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

Who this might be right for
Coronary Artery DiseaseAtrial Fibrillation
Boehringer Ingelheim 39,357
Not applicableStudy completedNCT03993119
What this trial is testing

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 500
Not applicableLooking for participantsNCT07385599
What this trial is testing

FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Lifetech Scientific (Shenzhen) Co., Ltd. 10
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableWithdrawnNCT02153424
What this trial is testing

Early Post-marketing Study of Eliquis (Apixaban)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Not applicableUnknownNCT04476147
What this trial is testing

The Impact of Frailty on Thrombosis of Elderly Patients With NVAF （FTE-NVAF）

Who this might be right for
Non-valvular Atrial Fibrillation, Elderly, Frailty, Thrombosis
Beijing Friendship Hospital 500
Large-scale testing (Phase 3)Study completedNCT02164864
What this trial is testing

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Who this might be right for
Atrial FibrillationPercutaneous Coronary Intervention
Boehringer Ingelheim 2,725
Not applicableStudy completedNCT05232643
What this trial is testing

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 636
Not applicableStudy completedNCT02690155
What this trial is testing

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Who this might be right for
Atrial Fibrillation
Bayer 38,831
Not applicableStudy completedNCT03508271
What this trial is testing

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Who this might be right for
Atrial FibrillationHeart Failure
Bristol-Myers Squibb 60,000
Not applicableStudy completedNCT05027061
What this trial is testing

Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Who this might be right for
Non-Valvular Atrial Fibrillation (NVAF)
Bristol-Myers Squibb 11,776
Not applicableStudy completedNCT02674594
What this trial is testing

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

Who this might be right for
Nonvalvular Atrial Fibrillation
Bristol-Myers Squibb 30,000
Not applicableLooking for participantsNCT06949319
What this trial is testing

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New Onset+4 more
Nedim Tojaga 150
Not applicableStudy completedNCT03119116
What this trial is testing

Use of Direct Oral Anticoagulants in UK

Who this might be right for
Stroke
Bayer 31,336
Next Page